Skip to main content

datastreet.in

Subscribe
Facebook-f Instagram Twitter Youtube

Novo Nordisk moves HC to stop Sun Pharma from launching weight loss drug

The dispute centres on Novo Nordisk’s Indian patents for semaglutide, which it markets globally as Ozempic and Wegovy for Type 2 diabetes and weight management

Source :- Companies Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *

Get free tips and resources right in your inbox, along with 10,000+ others

Categories

Latest Post

logo_neonews.png
Subscribe